Exploring the Ligand Efficacy of Cannabinoid Receptor 1 (CB1) using Molecular Dynamics Simulations
Abstract Cannabinoid receptor 1 (CB1) is a promising therapeutic target for a variety of disorders. Distinct efficacy profiles showed different therapeutic effects on CB1 dependent on three classes of ligands: agonists, antagonists, and inverse agonists. To discriminate the distinct efficacy profile...
Guardado en:
Autores principales: | Sang Won Jung, Art E. Cho, Wookyung Yu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/29d497457f834dadb0833af41d4d3654 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
1,2,3-Triazole derivatives as highly selective cannabinoid receptor type 2 (CB2) agonists
por: Amer H. Tarawneh, et al.
Publicado: (2022) -
Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses
por: Kenneth B. Walsh, et al.
Publicado: (2021) -
Localization of Cannabinoid Receptor 1 (CB1) in Submandibular and Sublingual Salivary Glands of Mice throughout Postnatal Development
por: Hipkaeo,Wiphawi, et al.
Publicado: (2015) -
Astroglial CB1 Cannabinoid Receptors Mediate CP 55,940-Induced Conditioned Place Aversion Through Cyclooxygenase-2 Signaling in Mice
por: Jin Cong, et al.
Publicado: (2021) -
The Impact of CB1 Receptor on Inflammation in Skeletal Muscle Cells
por: Haddad M
Publicado: (2021)